Impact of Gadolinium-enhancing (GD+) Lesions on No Evidence of Disease Activity (NEDA) Status in Subcutaneous Interferon Beta-1a (scifnβ-1a)-treated Patients

M. Freedman, G. Comi, P. K. Coyle, J. Aldridge, K. Marhardt, L. Kappos